Response to adriamycin and CCNU in a patient with IgD multiple myeloma and myelofibrosis.
D004317:Doxorubicin / Q000627:therapeutic use*; D006801:Humans; D007072:Immunoglobulin D; D007146:Immunoglobulin lambda-Chains; D008130:Lomustine / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000150:complications / Q000188:drug therapy*; D009607:Nitrosourea Compounds / Q000627:therapeutic use*; D055728:Primary Myelofibrosis / Q000150:complications*
D007072:Immunoglobulin D; D007146:Immunoglobulin lambda-Chains; D009607:Nitrosourea Compounds; D008130:Lomustine; D004317:Doxorubicin